BYRNE ASSET MANAGEMENT LLC Regeneron Pharmaceuticals, Inc. Transaction History

BYRNE ASSET MANAGEMENT LLC portfolio value:

$33,000
portfolio value

BYRNE ASSET MANAGEMENT LLC quarter portfolio value change:

+16.53%
quarter

Regeneron Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 5K $688.87 48
Q2 2022 share 0.00% 0 shares -6K $591.13 48
Q1 2022 share Decrease -11.11% -6 shares 0 $698.42 48
Q4 2021 share Increase 0.00% 54 shares 34K $642.51 54